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Four synthetic equivalents of (iPr2N)2P-OCH2CH2CN, 1, have been 
prepared from easily available enantiomerically pure -hydroxynitriles 
as well as from chiral -hydroxyesters. To demonstrate their possible 
use as phosphinating/resolving agents, these phosphorodiamidites have 
been used in the synthesis of known phosphoric acids. The method 
allows enantiomerically pure acids to be obtained via separation of the 
diastereomeric  
phosphates. The method should favourably compete with other 
resolution procedures, e.g. fractional crystallisation or chiral 
HPLC, for the small scale synthesis of new phosphoric acids 
for screening purposes. As synthetic equivalents of 1, these 
auxiliaries might find applications also in nucleoside chemistry 
for the synthesis of biologically relevant compounds. 
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Introduction 
The commercially available tetraisopropyl 2-cyanoethyl-
phosphorodiamidite 1 is a common reagent for the generation of 
cyanoethyl phosphates (RO)2P(O)(OCH2CH2CN) from alcohols or 
diols, mainly used bioorganic chemistry e.g. in carbohydrates, 
nucleotides and phospholipids chemistry. From these phosphates, 
the cyanoethyl group can be easily removed via base-induced 
elimination of acrylonitrile, to generate the corresponding 
phosphoric acids, phosphodiesters and others.[1][2] Chiral variants of 
phosphorodiamidite 1 might be highly useful auxiliaries for 
asymmetric syntheses via either diastereoselective processes or 
diastereomers separation. Chiral variants of this reagent could be 
prepared, in principle, from a variety of chiral alcohols bearing 
electron-withdrawing groups in their -positions (Figure 1), but 
compounds of this class have not been described in the literature. 
  
Figure 1. Targeted chiral analogues of 1 
We report here on the synthesis of new, structurally diverse chiral 
N,N,N,N-tetraisopropyl phosphorodiamidites that are easily 
available from chiral pool substrates. We demonstrate their use as 
synthetic equivalents of cyanoethyl phosphorodiamidite 1, both as 
phosphorylating agents and precursors for P(O)-OH functions.  
The use of these phosphorodiamidites has been typified here by a 
rather non-conventional application, i.e. the synthesis and resolution 
of chiral phosphoric acids, following to our recent work in this 
field.[3] However, synthetic uses of these chiral reagents in many 
different applications can be easily anticipated. 
Results and Discussion   
 Chiral phosphoric acids and the related phosphate salts have 
turned recently into highly useful auxiliaries and catalysts for a 
variety of enantioselective processes.[4] [5] Chiral phosphoric acids 
are mainly accessed from enantiomerically pure diols, e.g. Spinol,[6] 
BINOLs,[7] VANOL and VAPOL.[8] Alternatively, enantiomeric 
resolution of the phosphoric acid themselves may rely on 
crystallization of diastereomeric salts, e.g. brucine or cinchonidine 
derivatives,[9] or preparative HPLC separation of enantiomers. 
Crystallization processes are perfectly suited for large scale 
syntheses, while chiral HPLC, although expensive, is well adapted 
for small scale production of chiral samples for screening purposes. 
We propose here an alternative approach to phosphoric acids taking 
advantage of chiral auxiliaries, covalently bonded to the phosphorus 
atom via P-OR functions, and chromatographic separation of 
epimeric phosphites, or the corresponding phosphates (Figure 2).  
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Figure 2. Proposed synthesis and resolution procedure 
For such purpose, the chiral auxiliary must be easily removable so 
as to convert the intermediate phosphite epimers into the desired 
acid in a few steps. Surprisingly, this very intuitive strategy has not 
been applied so far to the synthesis and resolution of phosphoric acid 
precursors.  
Recently, during our studies on the synthesis of chiral phosphoric 
acids based on paracyclophane scaffolds shown in Scheme 1b,[3a] we 
have faced a crucial issue: the diol precursors being achiral, the 
common strategy of resolving the diol precursors couldn’t be applied 
in this series. Although chiral HPLC allowed resolution of the final 
chiral acids, this technique prevented however an easy and 
economically viable scale-up. This led us to envision the design of 
chiral phosphinating agents as synthesis/resolution tools, according 
to the strategy displayed in Figure 2 above. Thus, at the outset of this 
study, we have considered the (S)-3-hydroxy-3-
phenylpropanenitrile-derived phosphorodiamidite (S)-4 as a chiral 
synthetic equivalent of 1 (Scheme 1a), i.e. as a precursor for the 
phosphoric acid function.  
Nitrile (S)-3 is easily available from the enantiomerically enriched 
(R)-1-phenyl-2-chloroethanol 2: conversion of chloride 2 into nitrile 
3 by means of KCN occurs in 74% yield at a 7g scale. Then, addition 
of bis(diisopropylamino)chlorophosphine to (S)-3 in the presence of 
triethylamine affords the desired cyanoethyl-phosphorodiamidite 
(S)-4. Purification of this compound has been performed by quick 
filtration on a silica gel column with heptane/EtOAc (7:3) / Et3N 
(1%) as the eluent. (S)-4 has been obtained in 78% yield in 
multigram scale, as a stable, easy to handle crystalline solid.  
This chiral auxiliary has been used then in the synthesis and 
resolution of paracyclophane-based phosphoric acids as recalled in 
Scheme 1b.[3b] 
 
Scheme 1. (a) Synthesis of the chiral phosphorodiamidite (S)-4 and (b) use 
for the synthesis of paracyclophane-type phosphates.[3b] 
We illustrate here the potential usefulness of (S)-4, beyond the 
initially envisioned application, by typifying its use in the synthesis 
of some of the currently most popular chiral acids.  As shown in 
Scheme 2, phosphorodiamidite (S)-4 reacts with BINOL, VANOL 
and VAPOL to afford mixtures of the corresponding epimeric 
phosphites. Phosphites being rather air-sensitive, separation of the 
epimers is better performed on the corresponding phosphates 6 
which are obtained after oxidation of phosphorus with t-
butylhydroperoxyde. In all cases, pairs of epimers are easily 
separated by preparative HPLC at a 0.1 g scale in the conditions 
given in Scheme 2.  The single epimers of phosphates 6 have been 
fully characterized. The relative configurations of these phosphates 
have been assigned afterward, from the sign of the optical rotation 
of the corresponding acids 7a-c.[8a, 10] 
Finally, the cyanoethyl group has been removed by treatment with 
DBU, at room temperature in dichloromethane. The pure acids 7 
have been isolated after filtration of the DBU salts on a short silica 
gel column (removal of excess DBU and cinnamonitrile) and 
washing of the salt with a concentrated HCl solution. 
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Scheme 2. Synthesis of the phosphoric acids 7a-c by means of the chiral auxiliary (S)-4 
Beyond the atropisomeric biaryl-derivatives in Scheme 2, the 
method is illustrated also by the efficient separation of the spiranic 
phosphates 6d,d’, which are precursors for the spinol derived acid 
7d[6b] (Scheme 3). In this case, separation of the epimers does not 
require HPLC techniques, it can be carried out by column 
chromatography on silica gel (toluene/THF 9:1, Rf = 0.31 and 0.25). 
The (R, S)-phosphate 6d has been characterized by an X-ray crystal 
diffraction study. An ORTEP drawing for this compound is 
displayed in Scheme 3, showing that the spinol scaffold of 6d has an 
(R)-configuration.  
 
Scheme 3. Synthesis of the SPINOL-derived phosphoric acids 7d via the 
chiral auxiliary (S)-4 
Phosphates 6d and 6d’ have been converted into the 
corresponding acids by reaction with DBU, under the above 
conditions. 
The few experiments above validate our design of (S)-4 as a chiral 
auxiliary in the synthesis of phosphoric acids, as far as (S)-4 is 
readily available and allows easy separation of the diastereomeric 
phosphates in these four cases. Obviously, phosphates made by 
combining (S)-4 with other chiral scaffolds might challenge 
however chromatographic separations. Therefore, to ensure a 
general applicability of the proposed method (Figure 2), it would be 
preferable to have at our disposal a larger set of chiral auxiliaries.  
With this aim in mind, we have considered some new 
phosphorodiamidites as potential resolution agents (Scheme 4). 
Thus, we have prepared at first the (R)-ethyl 4-cyano-3-
hydroxybutanoate derived phosphorodiamidite (R)-8. This 
compound was anticipated to afford suitable phosphoric acid 
precursors, given its structural analogy to (S)-4 related to the 
presence of the -cyano-function. We have also envisioned that the 
range of phosphinating/resolving agents might be extended to 
phosphorodiamidites bearing withdrawing functions other than 
cyanides in their -positions. To check this point, we have prepared 
the new phosphorodiamidites 9 and 10 which display esters as the 
withdrawing functions (Scheme 4). These compounds have the main 
advantage of being easily obtained from commercially available, 
chiral pool substrates, i.e. malic acid and threonine esters 
respectively.  
 
 
 
Scheme 4.  Synthesis of the chiral phosphorodiamidites 8-10. 
Phosphorodiamidites 8-10 have been obtained in good yields from 
the corresponding chiral alcohols[11] by reaction with (iPr2N)2PCl 
and have been used most often without further purification. If 
needed, they can be purified by filtration on a short alumina column.  
The three phosphorodiamidites 8-10 have been tested initially as 
chiral resolving agents in the synthesis of planar chiral phosphoric 
acids with paracyclophane structures (Scheme 5). During these 
studies, we succeeded in the synthesis of the desired phosphates 11-
13 [11a,a’: 31P = -14.9 and -15.2 ppm (1:1 ratio); 12a,a’: 31P = -
14.0 and -14.5 ppm (6:4 ratio); 13a,a’: 31P = -13.2 and -14.5 ppm 
(2:8 ratio)] but unfortunately we couldn’t find suitable conditions for 
the separation of these epimeric mixtures.[12] 
 
Scheme 5. (a) Synthesis of epimeric mixtures of phosphates 10-12. 
Nevertheless, an interesting point has been noticed during these 
studies: the cyclization reaction between the ferrocenic diol 5a and 
the threonine-derived phosphorodiamidite (S)-10 generates the 
cyclic phosphates 13a,a’ as a 8:2 epimeric mixture, i.e. with a 
significant level of chiral induction at the ring closing step. Although 
the stereoselectivity level of these cyclizations must still be 
improved, this result opens the way to asymmetric syntheses of this 
class of chiral paracyclophanic derivatives. 
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Next, to check if phosphorodiamidites 8-10 can behave as chiral 
equivalents of 4 in the synthesis of phosphoric acids, we have 
considered VANOL as the model diol. All three 
phosphorodiamidites react with VANOL in the presence of 1H-
tetrazole in mild conditions to give the desired phosphites that are 
converted in situ into phosphates 14-16.  
 
Scheme 6. Synthesis of the VANOL-derived phosphoric acid 7b via the 
chiral auxiliaries 8-10. 
The epimers of phosphates 14-16 have been separated by HPLC 
under the conditions specified in the experimental section. Finally, 
all three chiral chains, including the amino-acid derived chain of 16, 
could be removed from the intermediate phosphates in the presence 
of DBU, leading to the VANOL derived phosphoric acid 7b. These 
experiments demonstrate that the ester functions of 9 and 10 play the 
same role as the cyano-function in 1 by favoring deprotonation of 
the -hydrogen atom and elimination of the corresponding olefins. 
Thus, phosphorodiamidites 8-10 can be envisioned for further uses 
as suitable, new chiral synthetic equivalents of the cyanoethyl 
phosphorodiamidite 1. 
 
Conclusion 
The successful experiments in Scheme 4 and Scheme 6 expand 
the scope of our new strategy of using chiral auxiliaries for the 
synthesis/resolution of phosphoric acids. They demonstrate that a 
variety of chiral-pool derived phosphorodiamidites, easily available 
in enantiomerically pure form, can be used for this purpose and 
provide therefore a suitable toolbox. As far as it offers a suitable 
resolution procedure, this new synthetic method may facilitate the 
development of new chiral scaffolds for phosphoric acid based 
catalysis. 
This work expands the range of chiral synthetic equivalents of 
cyanoethyl phosphorodiamidite 1 to -hydroxyesters derivatives. It 
highlights phosphorodiamidites 4, 8, 9 and 10 as chiral auxiliaries 
with potentially broad scope in different fields and applications, 
including chemical biology where the achiral analogue 1 is a well-
known privileged synthetic tool. 
Experimental Section 
Synthesis of the chiral phosphorodiamidites 4, 8, 9, 10. 
(1S)-2-cyanoethyl-1-phenyl N,N,N',N'-tetra-isopropylphosphorodiamidite 
(S)-4 has been prepared as reported previously.[3b] 
(R)-ethyl 3-((bis(diisopropylamino)phosphino)oxy)-4-cyanobutanoate 
(R)-8. To a suspension of bis(diisopropylamino)chlorophosphine (850 mg, 
3.18 mmol) in dry ether (10 mL) at 0 °C was added dropwise a solution of 
ethyl (R)-4-cyano-3-hydroxybutyrate (500 mg, 3.18 mmol) and 
triethylamine (488 L, 3.50 mmol) in dry ether (5 mL). The mixture was 
allowed to warm to room temperature and stirred overnight. The white solid 
was filtered off, the solution was evaporated under reduced pressure to afford 
the desired phosphorodiamidite (R)-8 (1.05 g, 85%). 31P NMR (202.5 Hz, 
CDCl3) : δ = 113.0 ppm; 
1H NMR (500.1 MHz, CDCl3) : δ = 4.22-4.17 (m, 
1H, OCH), 4.15-4.10 (m, 2H, OCH2), 3.55-3.47 (m, 4H, NCH), 2.86 (d, J = 
15.9, 4.8 Hz, 2H), 2.77 (dd, J = 15.9, 4.5 Hz, 1H), 2.70 (dd, J = 15.9, 8.4 Hz, 
1H), 1.25 (t, J = 7.0 Hz, 3H, Me), 1.17-1.15 (24H, CHMe2); 
13C NMR (75.5 
MHz, CDCl3) : δ = 170.1 (CO), 116.9 (CN), 65.6 (d, J = 18.9 Hz, OCH), 60.5 
(CH2), 44.8 (NCH), 44.6 (NCH), 39.5 (CH2), 39.4 (CH2), 24.3 (CH3), 24.1 
(CH3), 24.0 (CH3), 14.0 (CH3); IR : νmax =2969, 2932, 2872, 1733, 1459, 1392, 
1378, 1363, 1310, 1183, 1116, 1055, 1023, 954, 867, 708; HR-MS (ESI): m/z 
calcd. for C19H41N3O4P [M+H2O+H]
+, 406.2835. Found, 406.2831. []
20
D   = 
-16 (c = 1.5, CHCl3). 
 
(S)-Diethyl malate N,N,N’,N’-tetraisopropylphosphorodiamidite, (S)-9. 
Phosphorodiamidite (S)-9 was obtained in 92% yield (1.02 g) from 0.70 g 
(2.6 mmol) of bis(diisopropylamino)chlorophosphine and 500 mg  of L-(-)-
malate (2.6 mmol). 31P NMR (202.5 Hz, CDCl3) : δ = 118.9 ppm; 
1H NMR 
(500.1 MHz, CDCl3) : δ 4.52-4.44 (m, 1H, OCH), 4.19 (q, J = 7.2 Hz, 2H, 
OCH2), 4.12 (q, J = 7.2 Hz, 2H, OCH2), 3.60-3.47 (m, 4H, NCH), 2.87 (dd, 
J = 15.2, 6.1 Hz, 1H), 2.80 (dd, J = 15.2, 6.6 Hz, 1H), 1.29-1.21 (m, 6H, Me), 
1.17 (s, 12H, CHMe2), 1.15 (s, 12H, CHMe2); 
13C NMR (75.5 MHz, CDCl3) : 
δ= 172.1 (CO), 170.3 (CO), 69.6 (d, J = 18.2 Hz, OCH), 61.0 (CH2), 60.7 
(CH2), 45.1 (NCH), 44.9 (NCH), 39.5 (d, J = 4.6 Hz, CH2), 24.5 (CH3), 24.4 
(CH3), 24.3 (CH3), 14.3 (CH3), 14.2 (CH3); IR : νmax =2970, 2934, 2873, 1737, 
1464, 1369, 1245, 1180, 1157, 1116, 1095, 1024, 1024, 953, 867; HR-MS 
(ESI): m/z calcd. for C20H44N2O6P [M+H2O+H]
+, 439.2937. Found, 439.2939. 
[]
20
D   = -4.5 (c = 0.5, CHCl3) 
 
N-(tert-Butoxycarbonyl)-L-threonine methyl ester N,N,N’,N’-
tetraisopropylphosphorodiamidite, (2S,3R)-10. Phosphorodiamidite 
(2S,3R)-10 was obtained quantitative yield (3.5 g) from 2.0 g of 
bis(diisopropylamino)chlorophosphine (7.55 mmol)  and N-(tert-
butoxycarbonyl)-L-threonine methyl ester (1.76 g, 7.55 mmol). 31P NMR 
(202.5 Hz, CDCl3) : δ = 111.4 ppm; 
1H NMR (500.1 MHz, CDCl3): δ = 5.22 
(d, J = 9.6 Hz, 1H), 4.37-4.32 (m, 1H, OCH), 4.21 (d, J = 9.6 Hz, 1H), 3.71 
(s, 3H, Me), 3.53-3.40 (m, 4H, NCH), 1.45 (s, 9H, CMe3), 1.32 (d, J = 6.6 
Hz, 3H, Me), 1.18-1.15 (m, 24H, CHMe2); 
13C NMR (75.5 MHz, CDCl3) : δ 
= 171.5 (CO), 156.1 (CO), 79.5 (CMe3), 69.9 (d, J = 16.6 Hz, OCH), 59.0 (d, 
J = 4.1 Hz, CH), 52.0 (OCH3), 44.9 (NCH), 44.7 (NCH), 44.5 (NCH), 
 28.3 (CMe3), 24.5 (CH3), 24.4 (CH3), 24.2 (CH3), 24.1 (CH3), 19.3 (d, 
J = 8.1 Hz, CH3); IR : νmax =3447, 2968, 2930, 1758, 1717, 1485, 1460, 1362, 
1318, 1183, 1156, 1118, 1087, 1069, 1024, 1002, 953, 902, 866; HR-MS 
(ESI): m/z calcd. for C22H49N3O6P [M+H2O+H]
+, 482.3359. Found, 482.3344. 
[]
20
D   = +7.0 (c = 1.5, CHCl3). 
 
Representative procedure for the synthesis of phosphates 6 (Scheme 2 
and Scheme 3). A solution of (1S)-2-cyanoethyl-1-phenyl N,N,N',N'-tetra-
isopropylphosphorodiamidite (S)-4 (180 mg, 0.48 mmol) in anhydrous 1,2-
dichloroethane (5 mL) was added dropwise at r.t. to a solution of rac-BINOL 
(114 mg, 0.40 mmol) and 1H-tetrazole (117 mg, 1.67 mmol) in 1,2-
dichloroethane (20 mL). The mixture was heated at 80 °C for 3 h. The 
reaction was quenched by addition of saturated aqueous NaHCO3 (20 mL) 
and the mixture was extracted twice with DCM (2x20 mL). The organic 
phase was dried over MgSO4 and the solvents were removed under reduced 
Submitted to the European Journal of Organic Chemistry 5 
pressure. The crude phosphites (1:1 mixture of diastereomers,  31P = 146.7 
and 135.2 ppm) were engaged in the next step without further purification. 
Phosphites were dissolved in DCM (1 mL). TBHP (218 L, 5.5M in decane, 
1.20 mmol) was added to the solution at 0 °C. Then the reaction mixture was 
allowed to warm to room temperature and stirred for 30 minutes. After 
addition of saturated aqueous Na2S2O3, the layers were separated, the organic 
layer was dried over MgSO4 and concentrated in vacuo. The crude mixture 
was purified by chromatography on silica gel (heptane/EtOAc =6:4 to 4:6) 
to afford 120 mg of 6a,a’(63% yield). Phosphates 6a and 6a’ were separated 
by semi-preparative HPLC on a SiO2 column (250 x 10 mm, 5 mic) with a 
heptane/EtOAc gradient (8:2 to 4:6). 6a: retention time 16.7 min, 40 mg, 
33% yield; 6a’: retention time 17.7 min, 48 mg, 40% yield. 
6a: 31P NMR (202.5 Hz, CDCl3): δ = 1.5 ppm; 
1H NMR (500 MHz, CDCl3) : 
δ=8.04 (d, J = 8.9 Hz, 1H), 7.99 (d, J = 9.1 Hz, 1H), 7.97 (d, J = 9.1 Hz, 1H), 
7.92 (d, J = 8.4 Hz, 1H), 7.62 (d, J = 8.6 Hz, 1H), 7.49 (t, J = 6.6 Hz, 1H), 
7.46 (d, J = 8.6 Hz, 2H), 7.36-7.27 (m, 9H), 5.89 (ddd, JH,P = 7.6 Hz, J = 6.5, 
5.3 Hz, 1H, OCH), 3.10 (dd, J = 16.9, 5.3 Hz, 1H, CH2CN), 3.01 (dd, J = 
16.9, 6.5 Hz, 1H, CH2CN); 
13C NMR (125.8 MHz, CDCl3) : δ = 147.5 (d, JC-
P = 11.8 Hz, C-O), 146.2 (d, JC-P = 8.2 Hz, C-O), 136.6 (d, JC-P = 4.0 Hz, CPh), 
132.4 (C), 132.2 (C), 132.0 (C), 131.7 (CH), 131.6 (CH), 129.8 (CH), 129.2 
(CH), 128.7 (CH), 127.4 (CH), 127.3 (CH), 127.1 (CH), 127.0 (CH), 126.2 
(CH), 126.1 (CH), 126.0 (CH), 121.6 (C), 121.2 (C), 120.6 (CH), 115.8 (CN), 
76.9 (d, JC-P = 4.6 Hz, CH, OCH), 27.8 (d, JC-P = 6.7 Hz, CH2); IR : νmax 
=3064, 3015, 2927, 2853, 1620, 1591, 1508, 1465, 1434, 1362, 1296, 1227, 
1010, 977, 951, 748, 697. HR-MS (ESI): m/z calcd. for C29H21NO4P [M+H]
+: 
478.1208, Found: 478.1249; []
20
D   = +296 (c = 1, CHCl3). 
6a’: 31P NMR (202.5 Hz, CDCl3) : δ = 2.1 ppm; 
1H NMR (500.1 MHz, 
CDCl3) : δ = 8.04 (d, J = 9.0 Hz, 1H), 7.94 (d, J = 8.3 Hz, 1H), 7.91 (d, J = 
8.3 Hz, 1H), 7.83 (d, J = 8.8 Hz, 1H), 7.61 (d, J = 8.9 Hz, 1H), 7.50-7.43 
(7H), 7.35 (d, J = 8.8 Hz, 1H), 7.31-7.25 (3H), 6.76 (d, J = 8.8 Hz, 1H), 5.93 
(m, 1H, OCH), 3.04 (dd, J = 17.0, 6.3 Hz, 1H, CH2CN), 3.00 (dd, J = 17.0, 
6.3 Hz, 1H, CH2CN); 
13C NMR (125.8 MHz, CDCl3) : δ = 147.0 (d, JC-P = 
11.5 Hz, C-O), 146.0 (d, JC-P = 7.7 Hz, C-O), 136.3 (d, JC-P = 3.1 Hz, CPh), 
132.2 (C), 132.0 (C), 131.7 (C), 131.6 (CH), 131.0 (CH), 130.1 (CH), 129.2 
(CH), 128.6 (CH), 128.4 (CH), 127.2 (CH), 127.0 (CH), 126.9 (CH), 126.6 
(CH), 126.0 (CH), 125.9 (CH), 121.3 (C), 121.1 (C), 120.5 (CH), 120.0 (CH), 
115.1 (CN), 76.1 (d, JC-P = 3.7 Hz, OCH), 27.1 (d, JC-P = 6.5 Hz, CH2CN); 
IR : νmax =3067, 2928, 2854, 1620, 1591, 1508, 1464, 1294, 1227, 1009, 976, 
951, 896, 816, 729. HR-MS (ESI): m/z calcd. for C29H21NO4P [M+H]
+, 
478.1208. Found, 478.1203, []
20
D   = -329 (c = 1, CHCl3) 
 
Phosphates 6b and 6b‘ have been obtained via the same procedure (50% 
yield). They were separated by semi-preparative HPLC on a SiO2 column 
(250 x 10 mm, 5 mic) with a heptane/EtOAc gradient (8:2 to 4:6). 6b: 
retention time 9.6 min, 43% yield; 6b’: retention time 10.5 min, 40% yield. 
6b: 31P NMR (202.5 Hz, CDCl3): δ = 1.9 ppm; 
1H NMR (500.1 MHz, 
CDCl3) : δ = 8.45 (d, J = 8.3 Hz, 1H), 7.82 (d, J = 8.2 Hz, 1H), 7.78 (d, J = 
8.2 Hz, 1H), 7.74 (d, J = 8.3 Hz, 1H), 7.68 (t, J = 7.6 Hz, 1H), 7.60 (t, J = 
7.4 Hz, 1H), 7.50-7.48 (m, 3H), 7.43 (t, J = 7.4 Hz, 1H), 7.37-7.34 (m, 2H), 
7.28 (d, J = 7.3 Hz, 2H), 7.20 (t, J = 7.4 Hz, 1H), 7.11-7.05 (m, 2H), 6.93 (t, 
J = 7.5 Hz, 2H), 6.89 (t, J = 7.5 Hz, 2H), 6.47 (d, J = 7.5 Hz, 2H), 6.43 (d, J 
= 7.5 Hz, 2H), 6.11 (ddd, JH-P = 9.0 Hz, J = 7.2, 5.5 Hz, 1H, OCH), 3.05 (dd, 
J = 16.9, 7.2 Hz, 1H, CH2CN), 2.96 (dd, J = 16.9, 5.5 Hz, 1H, CH2CN); 
13C 
NMR (125.8 MHz, CDCl3) : δ = 145.8 (d, JC-P = 11.8 Hz, C-O), 144.8 (d, JC-
P = 8.2 Hz, C-O), 140.3 (C), 140.1 (C), 139.9 (d, J = 3.4 Hz, C), 136.4 (d, J 
= 4.4 Hz, C), 134.5 (C), 134.3 (C), 130.0 (CH), 129.2 (CH), 129.1 (CH), 
128.1 (CH), 127.9 (CH), 127.9 (CH), 127.8 (CH), 127.7 (CH), 127.4 (CH), 
127.0 (CH), 126.9 (CH), 126.8 (CH), 126.6 (CH), 125.9 (C), 125.7 (C), 125.1 
(C), 122.7 (CH), 122.6 (C), 122.3 (C), 122.2 (CH), 115.6 (CN), 77.4 (d, JC-P 
= 4.5 Hz, OCH), 27.5 (d, JC-P = 4.5 Hz, CH2CN); IR : νmax =3058, 3022, 2959, 
2927, 1593, 1566, 1489, 1362, 1289, 1009, 1000, 946, 760; HR-MS (ESI): 
m/z calcd. for C41H29NO4P [M+H]
+, 630.1834. Found, 630.1829. []
20
D   = -
177 (c = 1, CHCl3). 
6b’: 31P NMR (202.5 Hz, CDCl3) : δ = 1.4 ppm; 
1H NMR (500.1 MHz, 
CDCl3) : δ = 8.44 (d, J = 8.2 Hz, 1H), 7.84 (d, J = 8.2 Hz, 1H), 7.77 (d, J = 
8.2 Hz, 2H), 7.67 (t, J = 7.9 Hz, 1H), 7.61 (t, J = 7.9 Hz, 1H), 7.55-7.47 (m, 
4H), 7.39-7.32 (m, 5H), 7.10-7.06 (m, 2H), 6.90 (t, J = 7.9 Hz, 4H), 6.44 (d, 
J = 7.9 Hz, 2H), 6.41 (d, J = 7.9 Hz, 2H), 5.99 (ddd, J = 7.0, 6.3 Hz, JH,P = 
6.3 Hz, 1H), 3.04 (dd, J = 16.7, 7.0 Hz, 1H); 2.97 (ddd, J = 16.7, 6.3 Hz, JH,P 
= 1.9 Hz, 1H); 13C NMR (125.8 MHz, CDCl3) : δ = 146.0 (d, J = 11.4 Hz, 
C), 144.8 (d, JC-P = 9.0 Hz, C), 140.2 (d, JC-P = 5.6 Hz, C), 140.0 (C), 139.8 
(C), 136.4 (C), 134.5 (C), 134.4 (C), 130.1 (CH), 129.3 (CH), 129.2 (CH), 
129.1 (CH), 128.1 (CH), 127.9 (CH), 127.6 (CH), 127.4 (CH), 126.9 (CH), 
126.7 (CH), 125.7 (C), 125.4 (C), 122.6 (CH), 122.3 (CH), 115.6 (CN), 77.9 
(d, JC-P = 5.5 Hz, OCH), 27.3 (d, JC-P = 9.7 Hz, CH2CN); IR: νmax = 3057, 
2927, 2855, 1633, 1593, 1566, 1488, 1362, 1287, 998, 945, 906, 761; HR-
MS (ESI): m/z calcd. for C41H29NO4P [M+H]
+, 630.1834. Found, 630.1863, 
[]
20
D   = +96 (c = 1, CHCl3) 
 
Phosphates 6c and 6c‘ have been obtained via the same procedure (42% 
yield). They were separated by semi-preparative HPLC on a SiO2 column 
(250 x 10 mm, 5 mic) with a heptane/EtOAc gradient (8:2 to 5:5). 6c: 
retention time 11.1 min, 50% yield; 6c’: retention time 12.0 min, 40% yield. 
6c: 31P NMR (202.5 Hz, CDCl3) : δ = -3.0 ppm; 
1H NMR (500.1 MHz, 
CDCl3) : δ = 9.42-9.38 (m, 2H), 7.95 (d, J = 7.7 Hz, 1H), 7.83 (d, J = 8.6 Hz, 
1H), 7.78 (d, J = 7.6 Hz, 1H), 7.72-7.68 (m, 4H), 7.64 (d, J = 8.6 Hz, 1H), 
7.59 (s, 2H), 7.56-7.51 (m, 2H), 7.11 (t, J = 7.6 Hz, 2H), 7.07 (d, J = 7.6 Hz, 
1H), 6.99-6.90 (m, 6H), 6.70 (d, J = 7.6 Hz, 2H), 6.51 (t, J = 7.0 Hz, 4H), 
5.51 (ddd, JH,P = 7.7 Hz, J = 6.7, 4.7 Hz, 1H, OCH), 2.97 (dd, J = 16.8, 6.7 
Hz, 1H, CH2CN); 2.65 (dd, J = 16.8, 4.7 Hz, 1H, CH2CN); 
13C NMR (125.8 
MHz, CDCl3) : δ = 147.6 (d, JC-P = 11.1 Hz, C), 146.6 (d, JC-P = 8.1 Hz, C), 
141.6 (C), 141.3 (C), 139.4 (d, J = 3.3 Hz, C), 135.7 (d, J = 6.0 Hz, C), 135.1 
(C), 134.7 (C), 133.6 (C), 133.3 (C), 129.8 (CH), 129.6 (CH), 129.5 (CH), 
129.1 (CH), 129.0 (C), 128.6 (CH), 128.5 (CH), 128.3 (CH), 128.0 (CH), 
127.9 (CH), 127.8(CH), 127.7 (CH), 127.5 (CH), 127.4 (CH), 127.1 (CH), 
127.0 (CH), 126.7 (CH), 126.6 (CH), 125.7 (C), 125.5 (C), 125.2 (CH), 122.0 
(C), 121.4 (C), 115.1 (CN), 76.9 (d, JC-P = 5.3 Hz, OCH), 27.7 (d, JC-P = 4.6 
Hz, CH2CN); IR : νmax =3056, 2926, 1598, 1487, 1456, 1425, 1388, 1300, 
1232, 1124, 1016, 914, 890, 869, 751; HR-MS (ESI) m/z calcd. for 
C49H33NO4P [M+H]
+, 730.2147. Found, 730.2153; []
20
D   = -367 (c = 1.5, 
CHCl3). 
6c’: 31P NMR (202.5 Hz, CDCl3) : δ = -2.2 ppm; 
1H NMR (500.1 MHz, 
CDCl3) : δ = 9.67 (d, J = 8.6 Hz, 1H), 8.89 (d, J = 8.7 Hz, 1H), 8.03 (d, J = 
8.0 Hz, 1H), 7.89-7.84 (m, 3H), 7.78-7.74 (m, 3H), 7.65 (d, J = 8.7 Hz, 1H), 
7.61 (s, 1H), 7.57 (s, 1H), 7.53 (t, J = 7.6 Hz, 1H), 7.47-7.39 (m, 5H), 7.12-
7.08 (m, 3H), 6.95-6.91 (m, 4H), 6.55 (d, J = 8.6 Hz, 2H), 6.46 (d, J = 8.0 
Hz, 2H), 5.85 (ddd, JH,P = 8.0 Hz, J = 8.0, 3.8 Hz, 1H, OCH), 2.14 (dd, J = 
16.5, 8.0 Hz, 1H, CH2CN), 2.02 (dd, J = 16.5, 3.8 Hz, 1H, CH2CN); 
13C NMR 
(125.8 MHz, CDCl3) : δ = 147.6 (d, J = 11.1 Hz, C), 146.8 (d, J = 8.4 Hz, C), 
141.7 (C), 141.4 (C), 139.5 (d, J = 3.1 Hz, C), 137.0 (C), 135.0 (C), 134.9 
(C), 133.7 (C), 133.5 (C), 130.0 (CH), 129.7 (CH), 129.6 (CH), 129.5 (CH), 
129.4 (CH), 129.3 (CH), 129.0 (CH), 128.8 (C), 128.5 (CH), 127.9 (CH), 
127.8 (CH), 127.7 (CH), 127.6 (CH), 127.4 (CH), 127.3 (CH), 127.2 (CH), 
127.1 (CH), 127.0 (CH), 126.7 (CH), 126.3 (CH), 126.0 (C), 125.5 (C), 121.9 
(C), 121.5 (C), 114.7 (CN), 76.9 (d, J = 4.3 Hz, OCH), 26.5 (d, J = 10.9 Hz, 
CH2CN); IR : νmax =3059, 2926, 2854, 1598, 1558, 1456, 1387, 1300, 1231, 
1023, 1010, 914, 751; HR-MS (ESI): m/z calcd. for C49H33NO4P [M+H]
+: 
730.2147. Found, 730.2151; []
20
D   = +303 (c = 1.5, CHCl3). 
 
Phosphates 6d and 6d‘ have been obtained via the same procedure (88% total 
yield). They were separated on a Combiflash® system by using a silica gel 
column, with a toluene/THF gradient (99:1 to 94:6) as the eluent. 6d: Rf = 
0.2 (toluene/THF = 90:10), 48% yield; 6d’: Rf = 0.17, 40% yield. 
6d: 31P NMR (202.5 Hz, CDCl3): δ = -10.7 ppm; 
1H NMR (500.1 MHz, 
CDCl3) : δ = 7.46-7.44 (m, 3H), 7.41-7.38 (m, 2H), 7.26 (t, J = 7.4 Hz, 1H), 
7.17 (d, J = 7.4 Hz, 1H), 7.12 (t, J = 7.4 Hz, 2H), 7.03 (t, J = 7.4 Hz, 1H), 
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6.47 (d, J = 7.4 Hz, 1H), 5.81 (dt, JH,P = 8.2 Hz, J = 5.5 Hz, 1H, OCH), 3.14-
3.06 (m, 2H), 2.96 (d, J = 5.5 Hz, 2H), 2.90-2.81 (m, 2H), 2.31-2.24 (m, 2H), 
2.08-1.98 (m, 2H); 13C NMR (75.5 MHz, CDCl3) : δ = 146.8 (C), 146.6 (C), 
145.8 (d, J = 10.3 Hz, O-C), 144.3 (d, J = 7.1 Hz, O-C), 139.3 (d, J = 3.6 Hz, 
C), 138.8 (C), 136.3 (d, J = 5.7 Hz, CPh), 129.8 (CH), 129.0 (CH), 128.4 (CH), 
126.4 (CH), 123.4 (CH), 123.0 (CH), 121.5 (CH), 121.0 (CH), 115.3 (CN), 
76.1 (d, J = 4.8 Hz, OCH), 59.2 (C), 38.5 (CH2), 38.2 (CH2), 30.6 (CH2), 27.3 
(d, J = 5.0 Hz, CH2CN); IR : νmax =3018, 2956, 2856, 1616, 1584, 1466, 1293, 
1222, 1159, 1052, 1013, 997, 931, 905; HR-MS (ESI): m/z calcd. for 
C26H23NO4P [M+H]
+, 444.1365. Found, 444.1356. []
20
D   = -183 (c = 1, 
CHCl3). 
6d’: 31P NMR (202.5 Hz, CDCl3): δ = -11.4 ppm; 
1H NMR (500.1 MHz, 
CDCl3) : δ = 7.34-7.29 (m, 3H), 7.26-7.10 (m, 7H), 6.88 (d, J = 7.7 Hz, 1H), 
5.73 (dt, JH,P = 5.5 Hz, J = 5.5 Hz, 1H), 3.10 (dd, J = 16.9, 5.5 Hz, 1H), 3.08-
3.02 (m, 2H), 2.98 (dd, J = 16.9, 5.5 Hz, 1H), 2.84-2.78 (m, 2H), 2.25-2.20 
(m, 2H), 2.05-1.98 (m, 1H), 1.92-1.86 (m, 1H); 13C NMR (75.5 MHz, 
CDCl3) : δ = 146.8 (C), 146.6 (C), 146.1 (d, J = 10.4 Hz, O-C), 144.4 (d, J = 
7.1 Hz, O-C), 139.4 (C), 138.8 (C), 129.5 (CPh), 129.4 (CH), 128.9 (CH), 
128.8 (CH), 126.0 (CH), 123.3 (CH), 123.1 (CH), 121.3 (CH), 115.6 (CN), 
76.1 (d, J = 5.1 Hz, OCH), 59.3 (C), 38.5 (CH2), 38.2 (CH2), 30.6 (CH2), 27.7 
(d, J = 7.1 Hz, CH2CN); IR : νmax =3013, 2956, 2855, 1616, 1584, 1466, 1294, 
1222, 1159, 1132, 1054, 1014, 998, 931, 906, 790, 755; HR-MS (ESI): m/z 
calcd. for C26H22NO4PNa [M+Na]
+, 466.1184. Found, 466.1176. []
20
D   = 
+164 (c = 1, CHCl3). 
 
Synthesis of phosphates 14a,a’. To a solution of rac-VANOL (66 mg, 0.15 
mmol) and 1H-tetrazole (44 mg, 0.63 mmol) in anhydrous DCM (7.5 mL) 
was added dropwise a solution of ethyl 3-((bis(diisopropylamino)-
phosphino)oxy)-4-cyanobutanoate (R)-7 (70 mg, 0.18 mmol, 1.2 eq.) in 
anhydrous DCM (2 mL). The mixture was heated at 40 °C for 5 h. The 
reaction was then quenched by the addition of saturated aqueous NaHCO3 
(20 mL) and extracted twice with CH2Cl2. The organic phase was dried over 
MgSO4 and the solvents were removed under reduced pressure (
31P NMR 
(202.5 MHz, CDCl3): δ = 143.6 and 143.4 ppm). The mixture of phosphites 
was dissolved in CH2Cl2 (1 mL). TBHP (5.5M in decane, 82 L, 0.45 mmol) 
was added to the solution at 0 °C. Then the reaction mixture was allowed to 
warm to room temperature and stirred for 30 minutes. The reaction was 
treated with saturated aqueous Na2S2O3. The layers were separated, the 
organic layer was dried over MgSO4 and concentrated in vacuo. The crude 
mixture was purified by chromatography on silica gel (heptane/EtOAc = 6:4 
to 4:6) to afford 62 mg (65% yield) of 1:1 mixture of diastereoisomers. The 
phosphates 14a and 14a’ were separated by semi-preparative HPLC on a 
SiO2 column (250 x 10 mm, 5 mic), heptane/EtOAc gradient (8:2 to 4:6). 
10a: retention time 31.3 min, (22 mg, 35% yield); 14a’: retention time 31.6 
min, (20 mg, 32% yield). 
14a: 31P NMR (202.5 Hz, CDCl3): δ = 1.4 ppm; 
1H NMR (500.1 MHz, 
CDCl3): δ 8.44 (d, J = 8.5 Hz, 1H), 8.30 (d, J = 8.5 Hz, 1H), 7.87 (d, J = 8.0 
Hz, 1H), 7.84 (d, J = 8.0 Hz, 1H), 7.70 (t, J = 7.6 Hz, 1H), 7.66-7.60 (m, 3H), 
7.53 (s, 2H), 7.12 (m, 2H), 6.96-6.91 (m, 4H), 6.49-6.46 (m, 4H), 5.49-5.43 
(m, 1H, OCH), 4.24 (q, J = 7.2 Hz, 2H, OCH2), 3.09 (dd, J = 17.0, 5.0 Hz, 
1H), 2.98-2.93 (m, 2H), 2.85 (dd, J = 17.0, 7.5 Hz, 1H, CH2), 1.31 (t, J = 7.2 
Hz, 3H); 13C NMR (125.8 MHz, CDCl3): δ = 168.7 (CO), 145.8 (d, J = 12.0 
Hz, O-C), 144.7 (d, J = 8.3 Hz, O-C), 140.4 (C), 140.1 (C), 139.8 (C), 134.5 
(C), 134.3 (C), 129.2 (CH), 129.1 (CH), 128.2 (CH), 128.0 (CH), 127.9 (CH), 
127.9 (CH), 127.7 (CH), 127.6 (CH), 127.4 (CH), 127.2 (CH), 126.9 (CH), 
126.8 (CH), 125.7 (C), 125.2 (d, J =2.8 Hz, C), 122.6 (C), 122.5 (CH), 121.9 
(CH), 115.3 (CN), 72.2 (d, J = 4.7 Hz, OCH), 61.7 (CH2), 39.1 (d, J = 6.4 
Hz, CH2), 24.5 (CH2), 14.3 (CH3); IR: νmax = 3054, 3028, 2986, 1737, 1489, 
1362, 1301, 1290, 1025, 762, 700; HR-MS (ESI) : m/z calcd. for C39H31NO6P 
[M+H]+, 640.1889. Found: 640.1880; []
20
D    = +51 (c = 1, CHCl3). 
14a’: 31P NMR (202.5 Hz, CDCl3) : δ = 1.7 ppm; 
1H NMR (500.1 MHz, 
CDCl3) : δ = 8.45 (d, J = 8.5 Hz, 1H), 8.38 (d, J = 8.5 Hz, 1H), 7.85 (m, 2H), 
7.85 (m, 2H), ), 7.71 (t, J = 7.6 Hz, 2H), 7.65-7.61 (m, 2H), 7.53 (s, 1H), 7.52 
(s, 1H), 7.13-7.09 (m, 2H), 6.95-6.92 (m, 4H), 6.47-6.46 (m, 4H), 5.52-5.45 
(m, 1H, OCH), 4.12 (q, J = 7.5 Hz, 2H, OCH2), 3.13 (dd, J = 17.0, 5.4 Hz, 
1H),  3.02-2.97 (m, 2H), 2.86 (dd, J = 17.0, 7.0 Hz, 1H), 1.19 (t, J = 7.5 Hz, 
3H); 13C NMR (125.8 MHz, CDCl3) : δ = 168.7 (CO), 145.9 (d, J = 12.0 Hz, 
O-C), 144.7 (d, J = 9.2 Hz, O-C), 140.2 (C), 140.1 (C), 139.9 (C), 139.8 (C), 
134.5 (C), 134.3 (C), 129.1 (CH), 129.1 (CH), 128.1 (CH), 128.0 (CH), 127.9 
(CH), 127.7 (CH), 127.6 (CH), 127.5 (CH), 127.4 (CH), 126.8 (C), 126.8 (C), 
125.8 (d, J =1.8 Hz, C), 125.3 (d, J =2.8 Hz, C), 122.7 (C), 122.5 (CH), 122.3 
(C), 122.1 (CH), 115.3 (CN), 72.2 (d, J = 4.7 Hz, OCH), 61.5 (CH2), 39.0 (d, 
J = 4.5 Hz, CH2), 24.7 (d, J = 5.5 Hz, CH2), 14.2 (CH3); IR : νmax = 3055, 
3026, 2985, 2929, 1735, 1489, 1363, 1301, 1290, 1024, 967, 946, 762, 700; 
HR-MS (ESI) : m/z calcd. for C39H31NO6P [M+H]
+, 640.1889. Found, 
640.1882; []
20
D    = -89 (c = 1, CHCl3). 
 
Phosphates 15a,a’. Phosphates 15 have been prepared from rac-VANOL 
and diethyl (S)-malate N,N,N’,N’-tetraisopropylphosphorodiamidite (S)-9 as 
described for 14a,a’. The corresponding phosphites were obtained after 16h 
heating at 40°C (31P NMR (202.5 MHz, CDCl3): δ = 148.4 and 144.3 ppm). 
After oxidation, the crude mixture was purified by chromatography on silica 
gel (heptane/EtOAc = 6:4 to 4:6, 72% yield). Phosphates 15a and 15a’ were 
separated by semi-preparative HPLC on a Sunfire C18 reversed phase 
column, H2O/MeCN/Formic Acid (23/77/0.1). 15a: retention time 16.6 min; 
15a’: retention time 17.8 min. 
15a: 31P NMR (202.5 Hz, CDCl3): δ = 2.0 ppm; 
1H NMR (500.1 MHz, 
CDCl3): δ = 8.65 (d, J = 8.4 Hz, 1H), 8.51 (d, J = 8.4 Hz, 1H), 7.83 (d, J = 
8.1 Hz, 2H), 7.71-7.65 (m, 2H), 7.62-7.59 (m, 2H), 7.51 (s, 1H), 7.50 (s, 1H), 
7.12-7.08 (m, 2H), 6.93 (m, 4H), 6.48-6.46 (m, 4H), 5.71-5.67 (m, 1H, OCH), 
4.37 (q, J = 7.2 Hz, 2H, OCH2), 4.11 (q, J = 7.2 Hz, 2H, OCH2), 3.05-3.00 
(m, 1H), 2.95-2.90 (m, 1H), 1.38 (t, J = 7.2 Hz, 3H, Me), 1.15 (t, J = 7.2 Hz, 
3H, Me); 13C NMR (125.8 MHz, CDCl3): δ = 168.8 (CO), 168.4 (d, J = 3.6 
Hz, CO), 146.3 (d, J = 11.8 Hz, O-C), 144.9 (d, J = 9.2 Hz, O-C),  140.2 (C), 
140.1 (C), 140.0 (C), 139.9 (C), 134.5 (C), 134.3 (C), 129.2 (CH), 129.1 (CH), 
127.9 (CH), 127.8 (CH), 127.7 (CH), 127.6 (CH), 127.5 (CH), 127.2 (CH), 
126.9 (CH), 126.7 (CH), 126.0 (C), 125.6 (d, J = 2.8 Hz, C), 123.2 (CH), 
122.8 (CH), 122.3 (C), 74.3 (d, J = 5.3 Hz, OCH), 62.6 (OCH2), 61.4 (OCH2), 
37.9 (d, J = 5.4 Hz, CH2), 14.3 (CH3), 14.2 (CH3); IR : νmax = 3056, 2985, 
2937, 1760, 1738, 1489, 1363, 1305, 1291, 1181, 1110, 1048, 1029, 761, 
700; HR-MS (ESI): m/z calcd. for C40H34O8P [M+H]
+, 673.1991. Found, 
673.2017; []
20
D  = -43 (c = 1, CHCl3). 
15a’: 31P NMR (202.5 Hz, CDCl3): δ = 2.3 ppm; 
1H NMR (500.1 MHz, 
CDCl3) : δ = 8.51 (d, J = 8.2 Hz, 1H), 8.32 (d, J = 8.2 Hz, 1H), 7.84-7.82 (m, 
2H), 7.68 (t, J = 7.8 Hz, 1H), 7.64-7.57 (m, 3H), 7.52 (s, 1H), 7.49 (s, 1H), 
7.12-7.08 (m, 2H), 6.95-6.91 (m, 4H), 6.49-6.46 (m, 4H), 5.76-5.71 (m, 1H, 
OCH), 4.41-4.33 (m, 2H, OCH2), 4.19-4.11 (m, 2H, O CH2), 3.05 (dd, J = 
16.5, 4.8 Hz, 1H, CH2), 2.96 (dd, J = 16.5, 6.4 Hz, 1H, CH2), 1.36 (t, J = 7.1 
Hz, 3H, Me), 1.19 (t, J = 7.1 Hz, 3H, Me); 13C NMR (125.8 MHz, CDCl3) : 
δ = 168.7 (CO), 146.0 (d, J = 11.9 Hz, O-C), 145.0 (d, J = 8.2 Hz, O-C), 
140.3 (C), 140.1 (C), 140.0 (C), 139.9 (C), 134.5 (C), 134.3 (C), 129.2 (CH), 
129.1 (CH), 128.0 (CH), 127.9 (CH), 127.9 (CH), 127.6 (CH), 127.5 (CH), 
127.5 (CH), 127.2 (CH), 127.0 (CH), 126.8 (CH) 126.7 (CH), 126.1 (d, J = 
1.8 Hz, C), 125.5 (d, J = 2.6 Hz, C), 122.8 (CH), 122.7 (C), 122.5 (C), 122.3 
(CH), 74.2 (d, J = 5.4 Hz, OCH), 62.7 (OCH2), 61.4 (OCH2), 37.9 (d, J = 7.4 
Hz, CH2), 14.3 (CH3), 14.2 (CH3); IR : νmax = 2986, 2930, 1740, 1489, 1364, 
1306, 1291, 1262, 1182, 1110, 1049, 1030, 762, 751, 700; HR-MS (ESI) : 
m/z calcd. for C40H34O8P [M+H]
+, 673.1991. Found, 673.2001. []
20
D  = +95 
(c = 1, CHCl3). 
 
Phosphates 16a,a’. Phosphates 16 have been prepared from rac-VANOL 
(0.2 mmol) and N-(tert-Butoxycarbonyl)-L-threonine methyl ester 
N,N,N’,N’-tetraisopropylphosphorodiamidite (2S,3R)-10, as described for 
14a,a’. The corresponding phosphites (31P NMR: δ = 154.3 and 142.3 ppm 
ppm) were obtained after 16h heating at 40°C. After oxidation, the crude 
mixture was purified by chromatography on silica gel (heptane/EtOAc = 6:4 
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to 4:6, 78% yield). Phosphates 16a and 16a’ were separated by semi-
preparative HPLC on a Sunfire C18 column, H2O/MeCN/formic acid 
(20/80/0.1). 16a: retention time 12.0 min; 16a’: retention time 15.0 min. 
16a: 31P NMR (202.5 Hz, CDCl3): δ = 1.6 ppm; 
1H NMR (500.1 MHz, 
CDCl3) : δ 8.44 (d, J = 8.1 Hz, 1H), 8.32 (d, J = 7.8 Hz, 1H), 7.88 (d, J = 8.0 
Hz, 1H), 7.83 (d, J = 8.0 Hz, 1H), 7.71-7.59 (m, 4H), 7.53 (s, 1H), 7.51 (s, 
1H), 7.13-7.08 (m, 2H), 6.95-6.91 (m, 4H), 6.47 (d, J = 7.6 Hz, 4H), 5.54-
5.49 (m, 1H, OCH), 4.93 (d, J = 9.6 Hz, 1H), 4.44 (d, J = 9.6 Hz, 1H), 3.56 
(s, 3H, OMe), 1.65 (d, J = 6.3 Hz, 3H), 1.42 (s, 9H, CMe3); 
13C NMR (125.8 
MHz, CDCl3) : δ = 169.9 (CO), 155.9 (CO), 146.0 (d, J = 11.1 Hz, O-C), 
145.0 (d, J = 8.3 Hz, O-C), 140.3 (C), 140.1 (C), 139.9 (C), 139.8 (C), 134.5 
(C), 134.4 (C), 129.1 (CH), 128.1 (CH), 127.9 (CH), 127.8 (CH), 127.5 (CH), 
127.4 (CH), 127.2 (CH), 127.0 (CH), 126.8 (CH), 126.7 (CH), 125.9 (C), 
125.4 (C), 122.7 (C), 122.6 (CH), 122.5 (C), 122.2 (C), 80.4 (CMe3), 78.4 (d, 
J = 5.4 Hz, O-CH), 58.0 (d, J = 5.5 Hz, CH), 52.7 (OCH3), 28.4 (CMe3), 19.1 
(CH3); IR : νmax = 3426, 3057, 3009, 2980, 1749, 1718, 1490, 1364, 1301, 
1290, 1165, 1017, 968, 761, 700; HR-MS (ESI) : m/z calcd. for C42H39NO8P 
[M+H]+, 716.2413. Found, 716.2431; []
20
D  = -77 (c = 1, CHCl3). 
16a’: 31P NMR (202.5 Hz, CDCl3): δ = 2.1 ppm; 
1H NMR (500.1 MHz, 
CDCl3): δ = 8.47 (d, J = 8.4 Hz, 1H), 8.36 (d, J = 8.4 Hz, 1H), 7.87 (d, J = 
8.0 Hz, 1H), 7.84 (d, J = 8.5 Hz, 1H), 7.79 (t, J = 7.5 Hz, 1H), 7.69-7.59 (m, 
3H), 7.53 (s, 1H), 7.52 (s, 1H), 7.13-7.09 (m, 2H), 6.95-6.92 (m, 4H), 6.49-
6.46 (m, 4H), 5.60-5.54 (m, 1H, OCH), 5.06 (d, J = 9.6 Hz, 1H), 4.49 (d, J = 
9.6 Hz, 1H), 3.91 (s, 3H, OMe), 1.46 (d, J = 6.6 Hz, 3H, Me), 1.42 (s, 9H, 
CMe3); 
13C NMR (125.8 MHz, CDCl3): δ = 170.5 (CO), 156.0 (CO), 146.1 
(d, J = 12.0 Hz, O-C), 145.2 (d, J = 9.2 Hz, O-C), 140.3 (C), 140.1 (C), 139.9 
(C), 139.8 (C), 134.5 (C), 134.3 (C), 129.1 (CH), 128.1 (CH), 128.0 (CH), 
127.9 (CH), 127.6 (CH), 127.5 (CH), 127.3 (CH), 126.8 (CH), 126.7 (CH), 
125.7 (C), 125.5 (C), 122.7 (C), 122.5 (CH), 122.4 (CH), 80.4 (CMe3), 78.6 
(d, J = 5.5 Hz, OCH), 58.1 (d, J = 5.5 Hz, CH), 53.1 (OCH3), 28.4 (CMe3), 
18.9 (CH3); IR : νmax = 3430, 3056, 2979, 1752, 1721, 1490, 1363, 1302, 1291, 
1165, 1017, 968, 761, 700; HR-MS (ESI): m/z calcd. for C42H39NO8P 
[M+H]+, 716.2413. Found, 716.2441; []
20
D  =+118,5 (c = 1, CHCl3). 
 
Representative procedure for the removal of the chiral auxiliary. 
Phosphate 16a (36 mg, 0.05 mmol) was dissolved in DCM (1 mL) and DBU 
(15 L, 0.10 mmol) was added at room temperature. After 20 min, the crude 
7b·DBU salt was purified by column chromatography (eluent: DCM/MeOH 
gradient, from 100:0 to 90:10). The fractions were collected, concentrated in 
vacuo and diluted in DCM (10 mL). This solution was treated with HCl 6N 
(3*10 mL). The layers were separated and the organic layer was dried and 
concentrated in vacuo to afford the chiral phosphoric acid (R)-7b (25 mg, 
98% yield). Ee 98.8% by HPLC: CHIRALPAK® ID column, THF/n-
heptane 70/30, 0.3% TEA, 0.5% TFA, 4.7 mL/min. Retention times 5.7 min, 
for (R)-7b and 8.0 min, for (S)-7b. 
Supporting Information. 1H, 31P and 13C NMR spectra for the new 
compounds; X-ray data for 6d. 
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